iifl-logo

PGIM India Healthcare Fund Direct G

PGIM India Healthcare Fund Direct G

Fund Name

PGIM India Mutual Fund

Scheme Name

PGIM India Healthcare Fund Direct G

AMC

PGIM India Mutual Fund

Type

:  Open

Category

Equity - Pharma

Launch Date

19-Nov-2024

Fund Manager

Anandha Padmanabhan Anjen

Net Assets (Rs. cr)

107.37

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

PGIM India Healthcare Fund Direct G - Nav Details

Nav Date

:  16-Sep-2025

NAV [Rs.]

:  10.02

Buy/Resale Price [Rs.]

0

Sell/Repurchase Price [Rs.]

0

Entry Load %

Nil

Exit Load %

For Exits within 90 days from date of allotment of units: 0.50% For Exits beyond 90 days from date of allotment of units: NIL

PGIM India Healthcare Fund Direct G- NAV Chart

PGIM India Healthcare Fund Direct G- Performance(%)

Returns above 1 yr. are annualized

1W
1M
3M
6M
1Y
3Y
5Y
Since INC
Scheme Returns
0.9
-0.89
0.7
11.87
-
-
-
-0.09
Category Avg
1.04
0.28
2.61
13.13
-0.28
24.53
19.02
16.55
Category Best
2.41
3.5
5.12
16.95
9.57
29.72
22.03
34.35
Category Worst
0.31
-1.12
-0.24
9.23
-11.76
20.64
14.41
-2.25

PGIM India Healthcare Fund Direct G- Latest Dividends

No Records Found

PGIM India Healthcare Fund Direct G- Investment Details

Min. Investment(Rs.)

5000

Increm.Investment(Rs.)

1000

In & Out

In

InName Of The CompanyNo Of Shares
Dr Agarwal's Hea12,000

Out

InName Of The CompanyNo Of Shares
Sanofi India2,897

Fund Holdings

Asset Type
Instrument Name
Industry
Net Assets(%)
No of Shares
Mkt Value(Cr.)
Equity & Equity related Investments
EquitySun Pharma.Inds.Pharmaceuticals & Biotechnology12.288270813.18
EquityDivi's Lab.Pharmaceuticals & Biotechnology8.84154799.49
EquityMax HealthcareHealthcare Services7.48695918.03
EquityDr Reddy's LabsPharmaceuticals & Biotechnology6.44548916.91
EquityAster DM Health.Healthcare Services5.701018496.12
EquityMankind PharmaPharmaceuticals & Biotechnology5.17224455.54
EquityTorrent Pharma.Pharmaceuticals & Biotechnology5.11154005.48
EquityKrishna Institu.Healthcare Services3.95585774.24
EquityAbbott IndiaPharmaceuticals & Biotechnology3.4811883.73
EquityGlobal HealthHealthcare Services3.39264713.63
EquityAjanta PharmaPharmaceuticals & Biotechnology3.29142403.52
EquityPB Fintech.Financial Technology (Fintech)2.91176723.12
EquityDr Lal PathlabsHealthcare Services2.9194453.12
EquityCiplaPharmaceuticals & Biotechnology2.67180272.86
EquityJupiter Life LinHealthcare Services2.43184802.60
EquityICICI LombardInsurance2.40140182.57
EquityNavin Fluo.Intl.Chemicals & Petrochemicals2.2852192.44
EquityJ B Chemicals &Pharmaceuticals & Biotechnology2.17135142.33
EquityNeuland Labs.Pharmaceuticals & Biotechnology2.1216942.27
EquityRainbow Child.Healthcare Services2.10150352.25
EquityIpca Labs.Pharmaceuticals & Biotechnology2.07160842.22
EquitySai LifePharmaceuticals & Biotechnology2.05267362.20
EquitySagility IndiaIT - Services1.794373631.91
EquityAnthem BiosciencPharmaceuticals & Biotechnology1.33174571.42
EquityZydus Lifesci.Pharmaceuticals & Biotechnology1.08117661.15
EquitySyngene Intl.Healthcare Services1.04177911.11
EquityOrchid PharmaPharmaceuticals & Biotechnology0.81118050.86
EquityDr Agarwal's EyeHealthcare Services0.4911760.52
EquityDr Agarwal's HeaHealthcare Services0.48120000.51
Cash & Cash Equivalent
Reverse RepoC C I-/-1.6801.80
Net CA & OthersNet CA & Others-/-0.0600.06

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

MY WEALTH AT RETIREMENT

Calculate the worth of your wealth at retirement

Key information

Fund House:
PGIM India Mutual Fund
Incorporation Date:
24-Sep-2008
Total Assets Managed (Cr.):
25,211.92
Trustee/s:
Rakesh Sood, PGIM India Trustees Priva, Mr. Vijay Agarwal, Mr. Sujal Shah, Mr. John Praveen, Mr. Ashwini Kakkar
Chairman:
NA
CEO / MD:
Ajit Menon, Abhishek Tiwari
CIO:
NA
President:
NA
Director/s:
Mr.Muralidharan Rajamani, Glenwyn Peter Baptist, Kapil Wadhawan, Mr.David Wan Chang, Mr.Indrasena Yala Reddy, Dr. V. R. Narasimham
Compliance Officer/s:
Mr. Sandeep Kamath, Mr. Sumesh Kumar
Investor Service Officer/s:
Murali Ramasubramanian
Fund Manager/s:
Anandha Padmanabhan Anjen
Auditors:
Price Waterhouse Chartere

OTHER INFORMATION

Registered Office:
4th Floor, C Wing, Laxmi Towers, Bandra Kurla Complex, Bandra (East), Mumbai - 400 051
Contact Nos:
022-61593000
Fax:
022-61593100
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.